Top View
- Adverse Effects and Precautions Pharmacokinetics Uses And
- United States Patent (19) 11 Patent Number: 5,939,095 Hille Et Al
- Experimental and Established Oximes As Pretreatment Before Acute Exposure to Azinphos-Methyl
- Scientific Advisory Board
- A Comparison of the Potency of the Oxime Hlö-7
- Biomed 153-4.Indb
- Pharmacology/Toxicology Case Studies
- Novel Group of Ache Reactivators—Synthesis, in Vitro Reactivation and Molecular Docking Study
- An in Vitro Nerve Agent Brain Poisoning Transwell Model for Convenient and Accurate Antidote and Nanomedicine Evaluation
- Nerve Agents
- Added Value of Physos Gmine?
- Threat by Nerve Agents: Update of Diagnostic and Therapeutic Strategies!
- Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
- Success of Pyridostigmine, Physostigmine, Eptastigmine and Phosphotriesterase Treatments in Acute Sarin Intoxication
- 1 Reactivation and Resurrection of Organophosphorus Poisoned
- Proposal for the Inclusion of Pralidoxime in the Who Model List of Essential Medicines
- Mp-Hfm-149-T
- Neuroprotective Efficacy of Newly Developed Oximes in Comparison with Currently Available Oximes in Tabun-Poisoned Rats
- HI-6, Obidoxime, Trimedoxime, K027, K075, K127, K203, K282): Structural Evaluation of Human Serum Albumin Binding and Absorption Kinetics
- General Discussion-Session VI
- C:\Documents and Settings\Doktorová\Plocha\JAB\Soukup8 2\JAB Soukup8 2 Imprim.Wpd
- Pharmacological Therapies Against Soman-Induced Seizures in Rats 30
- Organophosphorus (OP) Nerve Agents and Countermeasures
- K-Oxime (K-27): Phosphylation-Induced Changes in Log P
- Pursuing the Complexity of Alzheimer's Disease
- The OPCW Science & Technology Monitor